CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced the expansion of its management team with the appointment of two individuals to key positions. The company named Stuart Pollard, Ph.D., to the position of Vice President, Scientific and Business Strategy, and Donna Ward, Ph.D., to the position of Vice President, Intellectual Property.
